Pain
From the Journals
Short-term NSAIDs appear safe for high-risk patients
The findings challenge the Choosing Wisely campaign of the American Society of Nephrology, which recommends against NSAIDs for high-risk patients...
From the Journals
Amitriptyline may be an alternative treatment for chronic low back pain
FDA/CDC
Emgality approved for migraine prevention in adults
The calcitonin gene–related peptide antagonist was tested in both episodic and chronic migraine.
Daily News Podcast
Does America have a gabapentinoid problem?
And atrial fibrillation guidelines may miss the mark with oral anticoagulation.
Latest News
House, Senate agree on broad opioid legislation
Huge bill to address the opioid epidemic contains many provisions that will affect physicians.
Conference Coverage
Signs point to growing abuse of gabapentinoids in the U.S.
LAS VEGAS – Several states have made gabapentin a Schedule V controlled substance while others have mandatory reporting of its dispensing and...
Conference Coverage
Ketamine infusions may be helpful in central sensitization pain syndromes
Opinion
Pregnancy registries are a valuable resource
From the Journals
Opioid use predicts longer sleep latency in chronic pain patients
Adults taking opioids for low levels of chronic pain reported greater difficulty falling asleep, compared with those who didn’t use opioids.
Latest News
Confirmed: Growth in overdose deaths is exponential
Opioid epidemic appears to be “the most recent manifestation of a more fundamental, longer-term process.”
News from the FDA/CDC
FDA issues new REMS for immediate-release opioids
For the first time, training will be made available to health care providers, nurses, and pharmacists involved in pain management.